Neurology

Scientists discover how to stop cells from attacking healthy tissue.

Multiple sclerosis patients who used a balance board accessory for a video game console saw changes in brain connections and improved their balance.

Phase I study deems treatment safe and tolerable in humans.

Phase I study deems treatment safe and tolerable in humans.

Specialty therapies for rheumatoid arthritis, multiple sclerosis, and breast cancer tended to have positive functional and clinical outcomes for patients.

Hospitalization rates for heart disease and stroke have dropped significantly over the past decade.

The viral Ice Bucket Challenge and the first effort to estimate the prevalence of amyotrophic lateral sclerosis have raised awareness of the neurodegenerative disease.

We should not be ashamed to talk openly about something that is nothing more than a neurotransmitter imbalance.

Many patients with Parkinson's disease do not receive treatment for their depressive symptoms.

Grocery store chain joins growing list of major companies offering enhanced specialty pharmacy.

The FDA has approved peginterferon beta-1a (Plegridy), a groundbreaking injectable therapy for patients with relapsing forms of multiple sclerosis.

Fall and injuries in the elderly may be attributed to many popular prescription medications.

A previous heart operation and recent struggles with the early stages of Parkinson's disease may have contributed to Robin Williams' suicide.

A woman taking Parkinson's disease drugs was admitted to a hospital for excessive, unwanted orgasms related to the drug.

Patients who told their employer about a multiple sclerosis diagnosis tended to have better odds of remaining employed and had a longer tenure than those who did not.

Increasingly, sharing of information online through social media has made blinding of placebo groups in clinical trials virtually impossible. In some disease states, particularly multiple sclerosis, virtual placebo groups may offer a solution.

Treatment with dimethyl fumarate improved or stabilized health-related quality of life scores in patients with relapse-remitting multiple sclerosis compared to placebo.

Taking more than 5 medications was associated with fatigue and memory problems in multiple sclerosis patients, a new study reports.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses challenges for specialty pharmacy in the management of patients with multiple sclerosis.

Role of specialty pharmacies in treatment of multiple sclerosis discussed during annual Armada summit.

Opexa Therapeutics is initiating a phase IIb trial of a novel therapy that targets T-cells in patients with secondary progressive multiple sclerosis.

The cooperative meeting of CMSC and ACTRIMS in Dallas platforms latest treatment, research and resources for MS health care professionals.

Patients taking Rebif (interferon beta-1a) may ask specialty pharmacists about recent reports of an increased risk of malignant hypertension with this specific formulation of interferon beta-1a.

Researchers in the United Kingdom have shown a reduction in the rate of brain atrophy progression with use of 80-mg simvastatin daily in patients with secondary-progressive multiple sclerosis over a 2-year period.

Integrated clinical and specialty pharmacy practice model includes an interdisciplinary team of physicians, nurses, and pharmacists.

Suzanne Tschida, PharmD, BCPS, vice president of specialty benefit and outcomes strategy at OptumRx, talks about how specialty medications are better suited for distribution through a specialty pharmacy over a retail location.

Although attention-deficit/hyperactivity disorder is a long-term condition, it can be managed with proper treatment.

Although attention-deficit/hyperactivity disorder is a long-term condition, it can be managed with proper treatment.